| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| BAK1 | BCL2 | ENSVVUP00000035663 | ENSVVUP00000024185 | Bcl-2 homologous antagonist/killer isoform X2. | Apoptosis regulator Bcl-2. | 0.989 |
| BAK1 | BCL2L1 | ENSVVUP00000035663 | ENSVVUP00000011411 | Bcl-2 homologous antagonist/killer isoform X2. | Bcl-2-like protein 1. | 0.995 |
| BAK1 | BCL2L11 | ENSVVUP00000035663 | ENSVVUP00000038500 | Bcl-2 homologous antagonist/killer isoform X2. | Bcl-2-like protein 11 isoform X2. | 0.973 |
| BAK1 | BIK | ENSVVUP00000035663 | ENSVVUP00000001191 | Bcl-2 homologous antagonist/killer isoform X2. | Bcl-2-interacting killer. | 0.722 |
| BAK1 | BOK | ENSVVUP00000035663 | ENSVVUP00000031263 | Bcl-2 homologous antagonist/killer isoform X2. | Bcl-2-related ovarian killer protein. | 0.448 |
| BAK1 | LOC112923323 | ENSVVUP00000035663 | ENSVVUP00000005445 | Bcl-2 homologous antagonist/killer isoform X2. | Bcl-2-related protein A1-like. | 0.856 |
| BAK1 | MCL1 | ENSVVUP00000035663 | ENSVVUP00000015727 | Bcl-2 homologous antagonist/killer isoform X2. | Induced myeloid leukemia cell differentiation protein Mcl-1. | 0.957 |
| BAK1 | PMAIP1 | ENSVVUP00000035663 | ENSVVUP00000021763 | Bcl-2 homologous antagonist/killer isoform X2. | Phorbol-12-myristate-13-acetate-induced protein 1. | 0.709 |
| BARD1 | BIK | ENSVVUP00000012347 | ENSVVUP00000001191 | BRCA1-associated RING domain protein 1. | Bcl-2-interacting killer. | 0.705 |
| BARD1 | BRCA1 | ENSVVUP00000012347 | ENSVVUP00000033145 | BRCA1-associated RING domain protein 1. | Breast cancer type 1 susceptibility protein homolog; E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain [...] | 0.998 |
| BCL2 | BAK1 | ENSVVUP00000024185 | ENSVVUP00000035663 | Apoptosis regulator Bcl-2. | Bcl-2 homologous antagonist/killer isoform X2. | 0.989 |
| BCL2 | BCL2L1 | ENSVVUP00000024185 | ENSVVUP00000011411 | Apoptosis regulator Bcl-2. | Bcl-2-like protein 1. | 0.995 |
| BCL2 | BCL2L11 | ENSVVUP00000024185 | ENSVVUP00000038500 | Apoptosis regulator Bcl-2. | Bcl-2-like protein 11 isoform X2. | 0.997 |
| BCL2 | BIK | ENSVVUP00000024185 | ENSVVUP00000001191 | Apoptosis regulator Bcl-2. | Bcl-2-interacting killer. | 0.994 |
| BCL2 | BOK | ENSVVUP00000024185 | ENSVVUP00000031263 | Apoptosis regulator Bcl-2. | Bcl-2-related ovarian killer protein. | 0.482 |
| BCL2 | MCL1 | ENSVVUP00000024185 | ENSVVUP00000015727 | Apoptosis regulator Bcl-2. | Induced myeloid leukemia cell differentiation protein Mcl-1. | 0.828 |
| BCL2 | PMAIP1 | ENSVVUP00000024185 | ENSVVUP00000021763 | Apoptosis regulator Bcl-2. | Phorbol-12-myristate-13-acetate-induced protein 1. | 0.982 |
| BCL2L1 | BAK1 | ENSVVUP00000011411 | ENSVVUP00000035663 | Bcl-2-like protein 1. | Bcl-2 homologous antagonist/killer isoform X2. | 0.995 |
| BCL2L1 | BCL2 | ENSVVUP00000011411 | ENSVVUP00000024185 | Bcl-2-like protein 1. | Apoptosis regulator Bcl-2. | 0.995 |
| BCL2L1 | BCL2L11 | ENSVVUP00000011411 | ENSVVUP00000038500 | Bcl-2-like protein 1. | Bcl-2-like protein 11 isoform X2. | 0.997 |
